DHES0815A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DHES0815A, covering 2024-08-05 to 2024-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer [Phase 1]

See pricing